Rankings
▼
Calendar
RCUS Q1 2020 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RCUS
Arcus Biosciences, Inc.
$2B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+0.0% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$28M
-1622.9% margin
Net Income
-$28M
-1585.9% margin
EPS (Diluted)
$-0.63
QoQ Revenue Growth
-82.1%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$176M
Total Liabilities
$36M
Stockholders' Equity
$141M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+0.0%
Gross Profit
$2M
$2M
+0.0%
Operating Income
-$28M
-$19M
-51.3%
Net Income
-$28M
-$18M
-57.1%
← FY 2020
All Quarters
Q2 2020 →